Abstract
Peripheral blood progenitor cell reinfusion (PBPC) in patients undergoing high-dose chemotherapy (HDC) for poor prognosis malignancies, has been described as causing possible acute gastrointestinal (nausea, vomiting), allergic (oedema, bronchospasm, anaphyl- axis), renal (proteinuria, haematuria) and/or cardiovascular (hypotension, arrhythmia, conduction disturbances, transient ischaemic phenomena) toxicities. To establish the clinical relevance of these observations and the possible relationship with different HDC regimens used, we performed a clinical and instrumental evaluation on 33 patients with advanced breast cancer, non-Hodgkin's lymphoma, Hodgkin's disease, relapsed ovarian cancer, Ewing's sarcoma, extragonadal germinal tumour and small cell lung cancer. They underwent at least one reinfusion each for a total of 51 studied procedures. No patient had a previous history of cardiovascular disease or significant intercurrent illness such as diabetes or liver, renal or neurologic impairment. All patients had totally implanted central venous catheters, through which the transplants had been collected and reinfused without technical consequences. To evaluate cardiovascular function, we continuously monitored 12-lead ECGs, with arterial pressure (AP) measurements every 5 min from the beginning of the procedure to 15 min after the reinfusion ended. We did not observe any significant differences between basal and subsequent steps in AP, heart rate, PQ and QTc time, P wave and QRS complex duration or P wave and QRS electrical axes. No patient showed any ST-T tract pathological abnormality, but one patient developed a transient ectopic atrial rhythm, without any haemodynamic disfunction and with spontaneous reversion to sinus rhythm. No patient complained of symptoms of haemodynamic failure. Gastrointestinal side-effects appeared to be strictly related to speed of reinfusion and to the number of packs reinfused, probably reflecting on the amount of dimethylsulphoxide infused. In one patient a tonic–clonic seizure occurred during a vomiting episode, but no patient developed allergic or renal toxicities. We conclude that PBPC reinfusion, if managed according to the procedure we propose in patients without organic impairment, is a safe procedure not associated either with increased risk of acute arrhythmias or ischaemic or significant systemic acute toxicities. Bone Marrow Transplantation (2000) 25, 173–177.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Styler MJ, Topolsky DL, Crilley PA et al. Transient high grade heart block following autologous bone marrow infusion Bone Marrow Transplant 1992 10: 435–438
Kupari M, Volin L, Suokas A et al. Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy finding Bone Marrow Transplant 1990 5: 91–98
Lopez-Jimenez J, Cervero C, Munoz A et al. Cardiovascular toxicity related to the infusion of cryopreserved grafts: result of a controlled study Bone Marrow Transplant 1994 13: 789–793
Keung YK, Lau S, Elkayam U et al. Cardiac arrhythmia after infusion of cryopreserved stem cells Bone Marrow Transplant 1994 14: 363–367
Miniero R, Saroglia E, Busca A et al. Electrocardiographic alterations occurring during cryopreserved bone marrow infusion (letter) Bone Marrow Transplant 1994 14: 664–665
Okamoto Y, Takaue Y, Saito S et al. Toxicities associated with cryopreserved and thawed peripheral blood stem cell autografts in children with active cancer Transfusion 1993 33: 578–581
Martinelli G, Peccatori F, Ullrich B et al . Multiple high dose chemotherapy with peripheral blood stem cell (PBSC) reinfusion in high risk breast cancer patients after anthracycline-containing primary chemotherapy (abstract). 23rd Annual Meeting of the European Group for Blood and Bone Marrow Transplantation, Aix-les-Bains, France, 1997, March 23–27
Leyvraz S, Perey L, Lange A et al . Sequential high dose ICE chemotherapy with circulating progenitor cells (CPC) in patients with small cell lung carcinoma (SCLC): an EBMT study Proc Am Soc Clin Oncol 1996 1133: (Abstr.) 379
Gianni AM, Siena S, Bregni M et al. Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease Ann Oncol 1991 2: 645–653
Gianni AM, Bregni M, Siena S et al . 5-year update of the Milan Cancer Institute randomised trial of high-dose sequential (HDS) vs MACOP-B therapy for diffuse large cell lymphomas Proc Am Soc Clin Oncol 1994 1263: (Abstr.) 373
Ravagnani F, Siena S, Bregni M et al. Large-scale collection of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSF Eur J Cancer 1990 26: 562–564
Kessinger A, Schmidt-Pokorny K, Smith D et al. Preservation and infusion of autologous peripheral blood stem cells Bone Marrow Transplant 1990 5: (Suppl.1) 25–27
Di Nicola M, Siena S, Bregni M et al. Benefits of blood cell transplant cryopreservation with oxypolygelatine (Gelifundol) plasma substitute Bone Marrow Transplant 1996 18: 619–623
Hahn U, Goldscmidt H, Salwender H et al. Large-bore central venous catheters for the collection of peripheral blood stem cells J Clin Apheresis 1995 10: 12–16
Siena S, Di Nicola M, Bregni M et al . Revised Milan protocol for CD34+ cell estimation in peripheral blood for autografting in patients with cancer. In: Wunder E, Sovalat H, Henon PR, Serke S (eds) Hematopoietic Stem Cells – The 1996 Mulhouse Manual AlphaMed Press 1996 pp 23–30
Biffi R, De Braud F, Orsi F et al. Totally implantable central venous access ports for long-term chemotherapy Ann Oncol 1998 9: 767–773
Salutari P, Sica S, Laurenti L et al. Incidence of sepsis after peripheral blood progenitor cells transplantation: analysis of 86 consecutive hemato-oncological patients Leuk Lymphoma 1998 30: 193–197
Keung YK, Watkins K, Chen SC et al. Increased incidence of central venous catheter-related infections in bone marrow transplant patients Am J Clin Oncol 1995 18: 469–474
Acknowledgements
We thank the nursing staff of the Hematoncology Unit (EIO) for their dedicated patient care, Dr R Biffi (Division of Surgery, EIO) for CVC placement to all patients and Drs P Lasagna, N Baruzzi for critical reviewing of the manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ferrucci, P., Martinoni, A., Cocorocchio, E. et al. Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy. Bone Marrow Transplant 25, 173–177 (2000). https://doi.org/10.1038/sj.bmt.1702120
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702120
Keywords
This article is cited by
-
Variation in hydration use after reinfusion of autologous stem cells in dimethyl sulfoxide (DMSO): a survey of EBMTcenters on behalf of the EBMT Nurses Group
Bone Marrow Transplantation (2023)
-
Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact
Bone Marrow Transplantation (2018)
-
Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion
Bone Marrow Transplantation (2014)
-
Historical perspectives and the future of adverse reactions associated with haemopoietic stem cells cryopreserved with dimethyl sulfoxide
Cell and Tissue Banking (2012)
-
DMSO-associated encephalopathy during autologous peripheral stem cell infusion: a predisposing role of preconditioning exposure to CNS-penetrating agents?
Bone Marrow Transplantation (2009)